Head-to-head comparison
Semaglutide vs Tesamorelin
Physician-reviewed comparison
Semaglutide
Peer ReviewedFDA Approved
A GLP-1 receptor agonist FDA-approved for type 2 diabetes and chronic weight management.
Tesamorelin
Peer ReviewedFDA Approved
An FDA-approved GHRH analog indicated for HIV-associated lipodystrophy.
Quick Comparison
| Dimension | Semaglutide | Tesamorelin |
|---|---|---|
| Category | glp1 | growth hormone secretagogue |
| Classification | GLP-1 Receptor Agonist | Growth Hormone Releasing Hormone Analog |
| Evidence Rating | Peer Reviewed | Peer Reviewed |
| Regulatory Status | FDA Approved | FDA Approved |
| Delivery | Subcutaneous injection, Oral tablet | Subcutaneous injection |
| Complexity | 4 / 5 | 4 / 5 |
| Refrigeration | Required | Required |
Dosing Comparison
Semaglutide
Weight Loss (Wegovy)
0.25–2.4 mg · weekly
Type 2 Diabetes (Ozempic)
0.5–2 mg · weekly
Tesamorelin
HIV Lipodystrophy (FDA-Approved)
1.4–2 mg · daily
Body Composition (Off-Label)
1–2 mg · daily
Can You Stack Them?
No known direct interaction between Semaglutide and Tesamorelin in our database. However, always consult your provider before combining compounds.
Medical Disclaimer
This comparison is for educational purposes only. Individual responses vary. Consult a qualified healthcare provider before using any compound.